KIT and gastrointestinal stromal tumor: Because imatinib is often administered for prolonged periods, proper management of imatinib-associated adverse events is crucial.<h4>Case report</h4>We report a 56-year-old man with metastatic KIT+ GIST of the liver who had Grade 3 imatinib intolerance (skin rash) when treatment was started.